Digital pathology involves converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. Digital pathology offers various advantages over traditional microscopy such as remote consultation and diagnosis, integrated diagnostic assistance, image sharing and collaboration. Rapid adoption of digital pathology solutions by diagnostic laboratories, academic & research institutes is fueling the market growth.
The Global Digital Pathology Market is estimated to be valued at US$ 994.95 Mn in 2024 and is expected to exhibit a CAGR of 12.% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the digital pathology are Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc., Nucleai, Inc. Rising prevalence of chronic diseases and growing requirement for long-term preservation and easy retrieval of slides is expected to boost demand for digital pathology solutions. Technological advancements in AI and machine learning are enabling the development of advanced imaging techniques, which is likely to provide new growth opportunities to key players in the digital pathology market.
Market Trends
The adoption of digital pathology is growing rapidly as it enables effective disease diagnosis. Integration of AI and machine learning capabilities is helping pathologists in disease identification, grading and management. Another key trend is the rising number of partnerships between digital pathology players and diagnostic labs & healthcare facilities to enhance diagnostic accuracy and operational efficiency.
Market Opportunities
Growing demand for telepathology and virtual pathology services from small labs and healthcare facilities in developing nations presents significant growth prospects. Also, the growing focus on personalized medicine is anticipated to boost adoption of digital pathology for drug discovery and clinical trials during the forecast period.
Fastest Growing Regional Market for Digital Pathology
The Asia Pacific region offers lucrative opportunities for players in the digital pathology market and is expected to emerge as the fastest growing regional market during the forecast period. Factors such as rapidly developing healthcare infrastructure, growing medical tourism industry and rising incidence of cancer are driving the adoption of digital pathology solutions across Asia Pacific countries. In addition, expanding patient pool coupled with initiatives to modernize diagnostic services will continue to augment market growth. The availability of low-cost technology solutions, expertise resource pool and government focus on digitization will further attract major market players to tap growth opportunities across Asia Pacific nations including India, China, South Korea and Japan. Ongoing collaborations between regional diagnostic laboratories and technology vendors are anticipated to boost the digital pathology market valuation in Asia Pacific during the forecast years.
Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide.
Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries.
Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care.
In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.Digital Pathology is an image-based information environment which is enabled by computer technology that allows for the management of information generated from a digital slide.
Digital pathology is enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed on a computer monitor.
Thus the pathologist no longer “reads” the physical slide under a microscope but the digital images on a monitor.
